ATE405669T1 - Remodellierung von glycoproteinen unter verwendung von endoglycanasen - Google Patents

Remodellierung von glycoproteinen unter verwendung von endoglycanasen

Info

Publication number
ATE405669T1
ATE405669T1 AT02786845T AT02786845T ATE405669T1 AT E405669 T1 ATE405669 T1 AT E405669T1 AT 02786845 T AT02786845 T AT 02786845T AT 02786845 T AT02786845 T AT 02786845T AT E405669 T1 ATE405669 T1 AT E405669T1
Authority
AT
Austria
Prior art keywords
glycoproteins
endoglycanases
remodeling
provides methods
recombinantly produced
Prior art date
Application number
AT02786845T
Other languages
English (en)
Inventor
Shawn Defrees
Karl Johnson
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Application granted granted Critical
Publication of ATE405669T1 publication Critical patent/ATE405669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT02786845T 2001-11-28 2002-11-27 Remodellierung von glycoproteinen unter verwendung von endoglycanasen ATE405669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33430101P 2001-11-28 2001-11-28

Publications (1)

Publication Number Publication Date
ATE405669T1 true ATE405669T1 (de) 2008-09-15

Family

ID=23306575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02786845T ATE405669T1 (de) 2001-11-28 2002-11-27 Remodellierung von glycoproteinen unter verwendung von endoglycanasen

Country Status (7)

Country Link
EP (1) EP1461445B1 (de)
JP (1) JP2005535280A (de)
AT (1) ATE405669T1 (de)
AU (1) AU2002351199A1 (de)
CA (1) CA2468295C (de)
DE (1) DE60228492D1 (de)
WO (1) WO2003046150A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
JP2006523211A (ja) 2003-03-14 2006-10-12 ネオス テクノロジーズ インコーポレイテッド 分岐水溶性ポリマーとその複合物
EP2338333B1 (de) 2003-04-09 2017-09-06 ratiopharm GmbH Glycopegylierungsverfahren und durch die Verfahren hergestellte Proteine/Peptide
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US7842661B2 (en) 2003-11-24 2010-11-30 Novo Nordisk A/S Glycopegylated erythropoietin formulations
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
ES2560657T3 (es) 2004-01-08 2016-02-22 Ratiopharm Gmbh Glicosilación con unión en O de péptidos G-CSF
CA2565414A1 (en) 2004-05-04 2005-11-24 Novo Nordisk Health Care Ag O-linked glycoforms of polypeptides and method to manufacture them
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
EP1799249A2 (de) 2004-09-10 2007-06-27 Neose Technologies, Inc. Glycopegyliertes interferon alpha
EP1797192A1 (de) * 2004-09-29 2007-06-20 Novo Nordisk Health Care AG Modifizierte proteine
SI2586456T1 (sl) 2004-10-29 2016-05-31 Ratiopharm Gmbh Preoblikovanje in glikopegliacija fibroblastnega rastnega faktorja (FGF)
EP1858543B1 (de) 2005-01-10 2013-11-27 BioGeneriX AG Glycopegylierten Granulocyten-Kolonie-stimulierender Faktor
JP4910091B2 (ja) * 2005-02-16 2012-04-04 国立大学法人北海道大学 ４位ハロゲン化ガラクトース含有糖鎖及びその応用
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
EP1987068B1 (de) 2006-02-10 2018-08-08 Life Technologies Corporation Modifizierung von oligosacchariden und etikettierung von proteinen
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
EP2054521A4 (de) 2006-10-03 2012-12-19 Novo Nordisk As Verfahren zur reinigung von polypeptid-konjugate
DK2101821T3 (da) 2006-12-15 2014-10-06 Baxter Healthcare Sa Faktor VIIA-(poly)sialinsyre-konjugat med forlænget halveringstid in vivo
ES2406267T3 (es) 2007-04-03 2013-06-06 Biogenerix Ag Métodos de tratamiento usando G-CSF glicopegilado
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
US8815580B2 (en) 2008-08-08 2014-08-26 Vib Vzw Cells producing glycoproteins having altered glycosylation patterns and method and use thereof
SI2889043T1 (sl) * 2008-12-16 2019-08-30 Genzyme Corporation Sintetične vmesne spojine za pripravo konjugatov oligosaharid-protein
KR20170124619A (ko) 2009-03-27 2017-11-10 아카데미아 시니카 바이러스에 대한 면역을 위한 방법 및 조성물
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
WO2011012850A2 (en) 2009-07-27 2011-02-03 Lipoxen Technologies Limited Glycopolysialylation of non-blood coagulation proteins
HUE028056T2 (en) 2009-07-27 2016-11-28 Baxalta GmbH Blood coagulation protein conjugates
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
JP5908401B2 (ja) 2009-07-27 2016-04-26 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 血液凝固タンパク質複合体
TWI537385B (zh) * 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法
CA2822591C (en) 2010-12-22 2020-12-29 Baxter International Inc. Materials and methods for conjugating a water soluble fatty acid derivative to a protein
US10851174B2 (en) 2011-03-03 2020-12-01 University Of Maryland, Baltimore Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereof
CA2862925C (en) 2012-02-10 2020-01-21 University Of Maryland, Baltimore Chemoenzymatic glycoengineering of antibodies and fc fragments thereof
US11293012B2 (en) 2015-07-09 2022-04-05 Vib Vzw Cells producing glycoproteins having altered N- and O-glycosylation patterns and methods and use thereof
AU2018322943B2 (en) 2017-09-04 2020-06-04 89Bio Ltd. Mutant FGF-21 peptide conjugates and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63502716A (ja) 1986-03-07 1988-10-13 マサチューセッツ・インステチュート・オブ・テクノロジー 糖タンパク安定性の強化方法
US5876980A (en) 1995-04-11 1999-03-02 Cytel Corporation Enzymatic synthesis of oligosaccharides
US6030815A (en) 1995-04-11 2000-02-29 Neose Technologies, Inc. Enzymatic synthesis of oligosaccharides
US5728554A (en) 1995-04-11 1998-03-17 Cytel Corporation Enzymatic synthesis of glycosidic linkages
US5922577A (en) 1995-04-11 1999-07-13 Cytel Corporation Enzymatic synthesis of glycosidic linkages
IL130964A0 (en) 1997-01-16 2001-01-28 Cytel Corp Practical in vitro sialylation of recombinant glycoproteins
JP2004528001A (ja) * 2000-05-12 2004-09-16 ネオーズ テクノロジーズ， インコーポレイテッド インビトロにおけるフコシル化組換えグリコペプチド

Also Published As

Publication number Publication date
WO2003046150A3 (en) 2003-11-27
WO2003046150A2 (en) 2003-06-05
EP1461445B1 (de) 2008-08-20
EP1461445A4 (de) 2005-08-17
DE60228492D1 (de) 2008-10-02
CA2468295C (en) 2010-08-03
CA2468295A1 (en) 2003-06-05
AU2002351199A1 (en) 2003-06-10
JP2005535280A (ja) 2005-11-24
EP1461445A2 (de) 2004-09-29

Similar Documents

Publication Publication Date Title
ATE405669T1 (de) Remodellierung von glycoproteinen unter verwendung von endoglycanasen
WO2003045980A3 (en) Glycopeptide remodeling using amidases
MXPA02011016A (es) Glicopeptidos recombinantes de glucolisacion in vitro.
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
EG23427A (en) Cultivated agarwood.
DE69635948D1 (de) Methoden zur modifikation von kohlenhydratanteilen
HK1046004A1 (en) Recombinant gelatins
ATE557544T1 (de) Adaptive filterung in abhängigkeit von der blockkantenstärke
BRPI0510295A (pt) preparação de uma glicoproteìna, e, método para produzir a mesma
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
BR0206429A (pt) Composição alvejante para a lavagem de roupa, método de branqueamento de um substrato, e, ligando
DE60316726D1 (de) Verfahren zur herstellung eines pressfilzes und pressfilz in form einer geschlossenen schleife
DE69901840D1 (de) Neue salzform von pantoprazol
DE50204861D1 (de) Vorrichtung zum erzeugen von weisslicht
NO20060093L (no) Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse derav
DE60336956D1 (de) Laserstrahlmaschine
DE69915310D1 (de) Methoden zur behandlung der salzabhängigen hypertonie
DK1078063T3 (da) BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis
DE60033576D1 (de) Methoden zum screening knochenmorphogenetishemimetika
ATE554426T1 (de) Verfahren zur ermöglichung der übertragung von im wesentlichen gleichen energiemengen
ATE330977T1 (de) Imidsalze als emulgatoren für die polymerisation von fluorolefinen
ATE323677T1 (de) Verfahren zur herstellung von 4-amino-2,5- bisheterocyclylchinazolinen
DK1112366T3 (da) Polynucleotider og polypeptider BASB033 fra Neisseria Meningitidis samt deres anvendelser
DE50211365D1 (de) Substituierte 1-phenethylpiperidinverbindungen, die unter anderem als analgetika verwendung finden
ATE259256T1 (de) Düse zur verdünnung von phosphorwasserstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties